Q3 2022 Holdings
Filed 2022-11-14 | 80 holdings | $411.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Contrafect Corp(CFRXUSD) | COM NEW | 212326300 | $79 | 472,300 | 0.0% |
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $523 | 190,815 | 0.0% |
| Galmed Pharmaceuticals LTD(GLMD) | SHS | M47238106 | $558 | 1,799,694 | 0.0% |
| Bionomics Limited(BNOXN) | ADS | 09063M205 | $578 | 80,971 | 0.0% |
| Erytech Pharma | SPONSORED ADR | 29604W108 | $690 | 1,314,656 | 0.0% |
| Angion Biomedica Corp | COM | 03476J107 | $986 | 1,071,297 | 0.0% |
| Aileron Therapeutics Inc(ALRNEUR) | COM | 00887A105 | $1.1K | 5,265,555 | 0.0% |
| MEI Pharma Inc | COM NEW | 55279B202 | $1.4K | 3,532,057 | 0.0% |
| X4 Pharmaceuticals Inc(ASNSUSD) | COM | 98420X103 | $1.5K | 847,879 | 0.0% |
| Forward Pharma A/S | SPONSORD ADS NEW | 34986J204 | $1.5K | 513,791 | 0.0% |
| Generation BIO Co(GBIOGBX) | COM | 37148K100 | $1.9K | 361,824 | 0.0% |
| Selecta Biosciences Inc(SELBUSD) | COM | 816212104 | $2.3K | 1,391,749 | 0.0% |
| Elevation Oncology Inc | COM | 28623U101 | $2.6K | 2,312,200 | 0.0% |
| Inventiva SA(IVA) | ADS | 46124U107 | $2.7K | 686,040 | 0.0% |
| Molecular Partners AG(MOLN) | ADS | 60853G106 | $3.0K | 443,221 | 0.0% |
| Molecular Templates Inc | COM | 608550109 | $3.7K | 4,996,565 | 0.0% |
| Spero Therapeutics Inc(SPRO) | COM | 84833T103 | $3.9K | 1,929,376 | 0.0% |
| Cidara Therapeutics Inc | COM | 171757107 | $4.3K | 6,861,127 | 0.0% |
| Glycomimetics Inc(GLYCEUR) | COM | 38000Q102 | $5.3K | 9,544,262 | 0.0% |
| Pyxis Oncology Inc(PYXS) | COMMON STOCK | 747324101 | $5.8K | 2,938,851 | 0.0% |
| Pieris Pharmaceuticals Inc | COM | 720795103 | $5.8K | 5,080,320 | 0.0% |
| Eledon Pharmaceuticals Inc(ELDN) | COM | 28617K101 | $6.4K | 2,326,710 | 0.0% |
| Hillevax Inc | COM | 43157M102 | $6.5K | 382,452 | 0.0% |
| Infinity Pharmaceuticals Inc(INFIQ) | COM | 45665G303 | $7.6K | 6,353,645 | 0.0% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $8.2K | 1,135,940 | 0.0% |
| Ikena Oncology Inc | COM | 45175G108 | $8.9K | 2,503,071 | 0.0% |
| Calliditas Therapeutics AB | SPONSERED ADS | 13124Q106 | $11.3K | 750,000 | 0.0% |
| Ovid Therapeutics Inc(OVID) | COM | 690469101 | $12.6K | 6,851,051 | 0.0% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $14.9K | 1,508,416 | 0.0% |
| Viracta Therapeutics Inc | COM | 92765F108 | $15.4K | 3,614,662 | 0.0% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $15.9K | 8,748,629 | 0.0% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $16.0K | 926,529 | 0.0% |
| Vigil Neuroscience Inc(VIGL) | COM | 92673K108 | $16.5K | 1,813,633 | 0.0% |
| Verastem Inc | COM | 92337C104 | $17.0K | 19,974,658 | 0.0% |
| Rain Therapeutics Inc | COM | 75082Q105 | $17.2K | 3,526,729 | 0.0% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $18.2K | 3,143,682 | 0.0% |
| Sutro Biopharma Inc | COM | 869367102 | $19.1K | 3,447,946 | 0.0% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $19.9K | 1,470,334 | 0.0% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $21.0K | 7,611,503 | 0.0% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $21.7K | 2,472,327 | 0.0% |
| Verve Therapeutics Inc | COM | 92539P101 | $22.3K | 650,000 | 0.0% |
| AC Immune SA(ACIU) | SHS | H00263105 | $23.5K | 7,428,379 | 0.0% |
| Concert Pharmaceuticals Inc(CNCEEUR) | COM | 206022105 | $24.3K | 3,629,000 | 0.0% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $27.7K | 6,894,345 | 0.0% |
| Eqrx Inc | COM | 26886C107 | $29.7K | 6,008,187 | 0.0% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $30.6K | 5,006,921 | 0.0% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $32.2K | 4,007,413 | 0.0% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $32.4K | 1,666,282 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $32.5K | 901,095 | 0.0% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $34.5K | 1,810,835 | 0.0% |